With the full spectrum technology onboard the Cytek® Aurora and Northern Lights, never before have we seen such high-sensitivity, high-parameter data from a fluorescence-based flow cytometer. Over the past 3 years, Cytek Biosciences has been expanding possibilities in our current fluorochrome-limited world through internal R&D, close collaboration with flow cytometry reagent companies, and through our growing community of users. Together, we have applied these new possibilities to meet today’s application needs.By exploring the full spectrum emitted from each fluorochrome, we have unlocked a more comprehensive and in-depth assessment of how these fluorochromes interact in a variety of applications; this knowledge has enabled our users to design experiments revealing biological populations that previously could not be easily resolved using fluorescence-based flow cytometry. We have also built a variety of tools that enable users to better evaluate compatibility and usability of fluorochromes together in a panel.Join us to learn more about how the Cytek® Aurora and Northern Lights measure the full spectrum emitted from each cell, allowing for expanded performance on an increasing number of applications.

Speakers
1) Aymeric Silvin, PhD, Institut Gustave Roussy
2) Maria Jaimes, Director of Applications, Cytek Biosciences
3) Richard Davis, MD, MD Anderson Cancer Center
4) Monica DeLay, MS, SCYM(ASCP)CM, US Manager - Technical Application Support, Cytek Biosciences

свернуть